Related references
Note: Only part of the references are listed.Minor Impact of A258D Mutation on Biochemical and Enzymatic Properties of Leishmania infantum GDP-Mannose Pyrophosphorylase
Wei Mao et al.
MICROORGANISMS (2022)
Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents
Aline N. Silva da Gama et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
Identification and evaluation of 4-anilinoquin(az)olines as potent inhibitors of both dengue virus (DENV) and Venezuelan equine encephalitis virus (VEEV)
Sirle Saul et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Synthetic and medicinal perspective of quinolines as antiviral agents
Ramandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
Charles E. Mowbray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Antileishmanial Drug Discovery and Development: Time to Reset the Model?
Ana Isabel Olias-Molero et al.
MICROORGANISMS (2021)
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues
Leentje Persoons et al.
ANTIVIRAL RESEARCH (2021)
Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
Miles B. Markus
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2021)
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Olivier J. Wouters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olines
Sirle Saul et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Chloroquine against malaria, cancers and viral diseases
Wenmin Zhou et al.
DRUG DISCOVERY TODAY (2020)
Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection
Lizzi Herrera et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2020)
Synthesis and biological evaluation of new quinoline derivatives as antileishmanial and antitrypanosomal agents
Santiago N. Chanquia et al.
BIOORGANIC CHEMISTRY (2019)
Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis
Katrien Van Bocxlaer et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2019)
Comparing the Efficacy of Oral Chloroquine versus Oral Tetracycline in the Treatment of Cutaneous Leishmaniasis
Fahmida Malik et al.
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN (2019)
Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis
Akanksha Upadhyay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
Susan Wyllie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis
Sebastien Pomel et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents
Ana Tejeria et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents
Akanksha Upadhyay et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study
Julien Pedron et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Fe3+ chelating quinoline-hydrazone hybrids with proven cytotoxicity, leishmanicidal, and trypanocidal activities
Juan Carlos Coa et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2018)
Antitrypanosomatid Pharmacomodulation at Position 3 of the 8-Nitroquinolin-2(1H)-one Scaffold Using Palladium-Catalysed Cross-Coupling Reactions
Julien Pedron et al.
CHEMMEDCHEM (2018)
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
Fabiana Alves et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Biochemical analysis of leishmanial and human GDP-Mannose Pyrophosphorylases and selection of inhibitors as new leads
Wei Mao et al.
SCIENTIFIC REPORTS (2017)
Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis
Gert-Jan Wijnant et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Comparative study of structural models of Leishmania donovani and human GDP-mannose pyrophosphorylases
Pierre Daligaux et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Simple and efficient synthesis of -aryl--deoxyguanosine analogs by azide-alkyne click reaction and their antileishmanial activities
Pierre Daligaux et al.
MOLECULAR DIVERSITY (2016)
In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route
Kaluvu Balaraman et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series
Charline Kieffer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Synthesis, characterization, and antileishmanial activities of gold(I) complexes involving quinoline functionalized N-heterocyclic carbenes
Lucie Paloque et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs
Vadiraj S. Gopinath et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Anti-leishmanial evaluation of C2-aryl quinolines: Mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis
Daznia Bompart et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents
Vadiraj S. Gopinath et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Activity of antimalarial drugs in vitro and in a murine model of cutaneous leishmaniasis
Vinicius Pinto Costa Rocha et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Quinolinic Alkaloids from Galipea longiflora Krause Suppress Production of Proinflammatory Cytokines in vitro and Control Inflammation in vivo upon Leishmania Infection in Mice
J. Calla-Magarinos et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Discovery of a new antileishmanial hit in 8-nitroquinoline series
Lucie Paloque et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Comparative Study of the Affinity and Metabolism of Type I and Type II Binding Quinoline Carboxamide Analogues by Cytochrome P450 3A4
Upendra P. Dahal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
IN SILICO ANALYSIS OF A THERAPEUTIC TARGET IN LEISHMANIA INFANTUM: THE GUANOSINE-DIPHOSPHO-D-MANNOSE PYROPHOSPHORYLASE
S. Pomel et al.
PARASITE (2012)
In Vitro Activities of New 2-Substituted Quinolines against Leishmania donovani
Philippe M. Loiseau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Increased Glycolytic ATP Synthesis Is Associated with Tafenoquine Resistance in Leishmania major
Jose Ignacio Manzano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The 8-Aminoquinoline Analogue Sitamaquine Causes Oxidative Stress in Leishmania donovani Promastigotes by Targeting Succinate Dehydrogenase
Luis Carvalho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Uptake of the antileishmania drug tafenoquine follows a sterol-dependent diffusion process in Leishmania
Jose Ignacio Manzano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
ANTILEISHMANIAL ACTIVITY OF A FORMULATION OF 2-N-PROPYLQUINOLINE BY ORAL ROUTE IN MICE MODEL
Campos N. Vieira et al.
PARASITE (2011)
SITAMAQUINE AS A PUTATIVE ANTILEISHMANIAL DRUG CANDIDATE: FROM THE MECHANISM OF ACTION TO THE RISK OF DRUG RESISTANCE
P. M. Loiseau et al.
PARASITE (2011)
Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine
Vanessa Yardley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Tafenoquine, an Antiplasmodial 8-Aminoquinoline, Targets Leishmania Respiratory Complex III and Induces Apoptosis
Luis Carvalho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Quinolines and structurally related heterocycles as antimalarials
Kirandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Mechanism of interaction of sitamaquine with Leishmania donovani
E. S. Coimbra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Sitamaquine Sensitivity in Leishmania Species Is Not Mediated by Drug Accumulation in Acidocalcisomes
Carmen Lopez-Martin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients
Femanda Grassi et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials
Nashira Campos Vieira et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani
Christian Bories et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Characterizing the Bi-Subunit Type IB DNA Topoisomerase of Leishmania Parasites; a Novel Scenario for Drug Intervention in Trypanosomatids
Rosa M. Reguera et al.
CURRENT DRUG TARGETS (2008)
Antileishmanial 2-substituted quinolines:: In vitro behaviour towards biological components
Julie Desrivot et al.
BIOMEDICINE & PHARMACOTHERAPY (2007)
Development of a SPE/HPLC/DAD method for the determination of antileishmanial 2-substituted quinolines and metabolites in rat plasma
Julie Desrivot et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Metabolism of 2-substituted quinolines with antileishmanial activity studied in vitro with liver microsomes, hepatocytes and recombinantly expressed enzymes analyzed by LC/MS
Julie Desrivot et al.
TOXICOLOGY (2007)
Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes
Ana Maria Duenas-Romero et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
8-aminoquinolines: future role as antiprotozoal drugs
Babu L. Tekwani et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis
Tracy Garnier et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases
H Nakayama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya
MK Wasunna et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2005)
Characterisation of a Leishmania mexicana knockout lacking guanosine diphosphate-mannose pyrophosphorylase
J Stewart et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2005)
Synthesis of substituted quinolines by iron-catalyzed coupling reactions between chloroenynes and Grignard reagents
M Seck et al.
TETRAHEDRON LETTERS (2004)
Biological evaluation of substituted quinolines
X Franck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Synthesis and biological evaluation of substituted quinolines:: Potential treatment of protozoal and retroviral co-infections
MA Fakhfakh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Substituted quinolines induce inhibition of proliferation of HTLV-1 infected cells
A Fournet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Decrease of intestinal P-glycoprotein activity by 2n-propylquinoline, a new oral treatment for visceral leishmaniasis
AM Belliard et al.
EXPERIMENTAL PARASITOLOGY (2003)
Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide -: A potential antileishmanial agent
NP Sahu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2002)
Iron-catalysed arylation of heteroaryl halides by Grignard reagents
J Quintin et al.
TETRAHEDRON LETTERS (2002)
Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi
R Dietze et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
Disruption of mannose activation in Leishmania mexicana:: GDP-mannose pyrophosphorylase is required for virulence, but not for viability
A Garami et al.
EMBO JOURNAL (2001)
Expeditious preparation of 2-substituted quinolines
MA Fakhfakh et al.
TETRAHEDRON LETTERS (2001)
Iron catalyzed hydrodebromination of 2-aryl-1,1-dibromo-1-alkenes
MA Fakhfakh et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2001)
Synthesis of 2-substituted trifluoromethylquinolines for the evaluation of leishmanicidal activity
J Dade et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2001)
Share Paper
